Podcast episode 28 (in German)
Prostamax & Prostagen: The prostate bioregulator fact-checked
July 5, 2026
A tiny peptide made of just 4 building blocks is supposed to keep the prostate specifically healthy and young. Prostamax comes from one of the most original ideas in the longevity world, a small signaling peptide of its own for every organ, developed in a Russian school of research.
What it is about
Prostamax, also called Prostagen, is a very short peptide and belongs to the bioregulators of the Russian scientist Vladimir Khavinson. Over decades, his school has described short peptides of their own for many organs, for the pineal gland, thymus, blood vessels and indeed the prostate; the best-known relative is epitalon. The theory behind it is epigenetic: the peptides are supposed to dock onto DNA and influence which genes are active in the tissue, without changing the genes themselves. Unlike testosterone, Prostamax does not act as a hormone. The episode explains what users hope for with an aging prostate, and separates the research tradition from what has been confirmed internationally. The conclusion is an elegant concept with open proof and a clear rule: screening comes first.
Key points
- Prostamax is a synthetic short peptide made of just 4 amino acids and the representative for the prostate in Vladimir Khavinson’s bioregulator family.
- The basic idea is epigenetic: the peptide is supposed to dock onto DNA and switch genes in the tissue back on that were silenced with age, without altering the genome.
- The Khavinson school has described short peptides for the pineal gland, thymus, blood vessels and prostate; the best-known relative is epitalon, the peptide of the pineal gland.
- This school has produced animal studies in which bioregulators were associated with a longer lifespan and better organ function.
- Anecdotal report: with a benign enlarged prostate, users hope for more normal urination, a stronger stream and getting up less at night; in the Russian tradition it is used as a course.
- In the Russian reports, the bioregulators are considered very well tolerated, partly because Prostamax is supposed to act not as a hormone but as an ordering signal for the tissue.
Where the data stop
Large, independent studies to Western standards that show a benefit in humans beyond doubt are rare. Much rests on the Khavinson school itself and on experience, and the mild safety picture also comes from these reports; robust long-term data are missing. Prostamax is not approved as a medicine in Germany, as of July 2026. What is available online is sold as a research chemical without quality control; purity is not assured without an independent lab report.
The most important point concerns the prostate itself: something serious can also lie behind similar symptoms. A peptide never replaces a urological workup and early detection with a PSA test and examination, not even when it subjectively feels good.
Listen (in German)
Listen on Spotify Listen on Apple Podcasts Listen on Amazon Music
Published on July 5, 2026.
The topic in the database
- A Russian bioregulator peptide for the prostate that is said to relieve BPH and prostatitis symptoms via an epigenetic approach – tissue-specif…Prostamax
All episodes in the app (German)
Information only, not medical advice and not a usage or dosage recommendation. Prescription-only and unapproved substances belong in the hands of a physician. Last updated: 2026-10-09.